US Venture Partner led a $42m Series C funding round in Iantrek.

US Venture Partner, a venture capital firm, led a $42m Series C funding round in Iantrek, a private company developing bio-interventional ophthalmic surgical solutions with participation from aMoon Fund, Visionary Ventures, Sectoral Asset Management, Radius Special Situations Fund, and Civilization Ventures. “This raise reflects strong confidence in Iantrek’s bold vision and disruptive approach to interventional glaucoma,” Casey Tansey, USVP General Partner.